Montana Hematology Oncology Conference

Whitefish, MT US
June 8, 2024

The Montana Hematology Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies. This conference will feature leading experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. The field of oncology is continually evolving with the introduction of new targeted therapies, cellular therapies, and immunotherapy. These advances present new opportunities to tailor treatment approaches for cancer patients based on disease-related and patient-related factors. Significant disparities exist in access to continuing education for physicians practicing in rural settings. Engaging, easily accessible continuing education activities focusing on content that has practical applications for the provider may significantly impact patient outcomes. There is a need for these educational activities in rural settings to update practicing healthcare providers about recent advances in the field. This highly practical and interactive symposium will provide a unique opportunity for healthcare professionals to learn from and interact with well-known experts in the field. 

Target Audience

  • Hematologist/Oncologists
  • Oncology Physician Assistants/Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Nurses

ORGANIZING COMMITTEE 

Course Director:

Binay Shah, MD, MHA Binaytara Foundation

Conference Chair

Srinivas Tantravahi, MBBS, MRCP - University of Utah Huntsman Cancer Institute

VENUE INFORMATION 

If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $289 per night plus applicable taxes and fees. The cut off date is May 7th, 2024:

Booking link: https://lodgeatwhitefishlake.com/groupslogin

Group ID: Binay24

Group Password: WHITEFISH

Learning Objectives

  1. Review pertinent clinical trial data for the standard of care and novel management strategies for common malignancies.
  2. Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care for cancer patients.
  3. Individualize management of cancer patients based on emerging data from clinical trials and evolving expert guidelines.
  4. Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact the management of common malignancies.

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
11/28/2023
Course expires: 
08/31/2024
Event starts: 
06/08/2024 - 7:00am PDT
Event ends: 
06/08/2024 - 4:00pm PDT
Cost:
$150.00

June 8, 2024

All times are listed in Mountain Standard Time (MST). 

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:05 AM  Welcome Remarks 

08:05 AM – 08:20 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:20 AM – 09:50 AM  Session 1: Women’s Cancers 

Moderator: Elizabeth Bigger, MD

08:20 AM – 08:50 AM  Non-Metastatic Breast Cancer - Recent Advances - Christos Vaklavas, MD

08:50 AM – 09:20 AM  Management of Metastatic Breast Cancer in 2024 - Stephen Kimani, MD, MSc

09:20 AM – 09:50 AM  Advances in Management of Ovarian Cancer - Elise J. Simons, MD, FACOG


09:50 AM – 10:00 AM  Break & Exhibits


10:00 AM – 12:00 PM  Session 2: General Oncology

Moderator: Jack Hensold MD

10:00 AM – 10:30 AM  Biomarker-Guided Treatment of Advanced Non-Small Cell Lung Cancer - Lei Deng, MD

10:30 AM – 11:00 AM  Advances in the Management of Advanced Prostate Cancer - Umang Swami, MD

11:00 AM – 11:30 AM  Management of Immunotherapy Toxicities - Kara Schenk, MD

11:30 AM – 12:00 PM  Panel Discussion


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM – 02:30 PM  Session 3: GI Oncology 

Moderator: Justin D Thomas, MD

01:00 PM – 01:30 PM  Advances in the Management of Colorectal Cancer - Ronan Hsieh, MD

01:30 PM – 02:00 PM  Updates in the Management of Gastric and GE junction Cancers - Shiven Patel, MD, FACP

02:00 PM – 02:30 PM  Panel Discussion 


02:30 PM – 03:00 PM  Break & Exhibits


03:00 PM – 04:00 PM  Session 4: Hematologic Malignancies

Moderator: Srinivas Tantravahi, MBBS, MRCP

03:00 PM – 03:30 PM  Recent Updates in Management of Diffuse Large B cell Lymphoma - Lindsey Fitzgerald, MD

03:30 PM – 04:00 PM  Updates in the Management of Multiple Myeloma - Douglas Sborov, MD, MS


04:00 PM – 04:05 PM  Adjourn

The Lodge at Whitefish Lake
1380 Wisconsin Ave.,
Whitefish, MT 59937
United States

If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $289 per night plus applicable taxes and fees. The cut off date is May 7th, 2024:

Booking link: https://lodgeatwhitefishlake.com/groupslogin

Group ID: Binay24

Group Password: WHITEFISH

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Conference Chair(s)

Srinivas Tantravahi, MBBS; MRCP

has a financial relationship (Professional Services) with CTI BioPharma;.
has a financial relationship (Professional Services) with AbbVie;.
has a financial relationship (Professional Services) with Novartis;.
has a financial relationship (Financial Support) with karyopharm therapeutics;.
has a financial relationship (Professional Services) with MorphoSys;.
Speaker/Topic Presenter(s)

Lei Deng, MD

has a financial relationship (Travel) with MJH Life Sciences;.
has a financial relationship (Other) with MJH Life Sciences;.

Lindsey Fitzgerald, MD

has no relevant financial relationships to disclose at this time.

Ronan Hsieh, MD, MS

has no relevant financial relationships to disclose at this time.

Stephen Kimani, MD, MSc

has no relevant financial relationships to disclose at this time.

Shiven Patel, MD, MBA, FACP

has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with Regeneron;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Takeda;.
has a financial relationship (Professional Services) with BMS;.

Douglas Sborov, MD MS

has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with GlaxoSmithKline;.
has a financial relationship (Professional Services) with Arcellx;.
has a financial relationship (Professional Services) with Bristol Myer Squibb;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Sanofi;.

Kara Schenk, MD

has a financial relationship (Professional Services) with Bristol Myers Squibb;.

Elise Simons, Clinical Assistant Professor, Division of Gynecologic Oncology, University of Washington

has no relevant financial relationships to disclose at this time.

Umang Swami, MD, MS

has a financial relationship (Other) with Seattle Genetics;.
has a financial relationship (Other) with AstraZeneca ;.
has a financial relationship (Other) with Exelixis;.
has a financial relationship (Other) with Sanofi ;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Other) with ImVax;.
has a financial relationship (Other) with Gilead;.

Christos Vaklavas, M.D., Associate Professor

has a financial relationship (Professional Services) with Guidepoint;.
has a financial relationship (Professional Services) with Gilead;.
has a financial relationship (Financial Support) with SeaGen;.
has a financial relationship (Employment) with Flatiron;.
has a financial relationship (Professional Services) with Daiichi Sankyo;.
has a financial relationship (Financial Support) with Pfizer;.
has a financial relationship (Financial Support) with CytomX;.
has a financial relationship (Professional Services) with SeaGen;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Financial Support) with AstraZeneca;.
has a financial relationship (Professional Services) with Novartis;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Financial Support) with H3 Biomedicine;.
Moderator(s)

Elizabeth Bigger

has no relevant financial relationships to disclose at this time.

Jack Hensold, MD

has no relevant financial relationships to disclose at this time.

Justin Thomas

has no relevant financial relationships to disclose at this time.

Acknowledgment of Commercial Support

This activity is supported with an independent Medical Education Grant from AstraZeneca.

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:

Link to register as an additional rep of a sponsoring company: https://education.binayfoundation.org/industry_registraiton_nocme 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.